Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Voelter, V; Diserens, AC; Moulin, A et al.

Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma.

Int J Cancer. Bd. 123. H. 5. 2008 S. 1215-8


Staszewski, O; Nikolova, T; Kaina, B

Kinetics of gamma-H2AX focus formation upon treatment of cells with UV light and alkylating agents

Environ Mol Mutagen. Bd. 49. H. 9. 2008 S. 734-40


Wiewrodt, D; Nagel, G; Dreimuller, N et al.

MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome.

Int J Cancer. Bd. 122. H. 6. 2008 S. 1391-9




Huber, S; Schrader, J; Fritz, G et al.

P38 MAP kinase signaling is required for the conversion of CD4+CD25 iTreg.

PLoS One. Bd. 3. H. 10. 2008 S. e3302



Strik, H; Buhk, JH; Wrede, A et al.

Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas

Mol Med Report. 2008 S. 863-867


Konkimalla, VB; Kaina, B; Efferth, T

Role of transporter genes in cisplatin resistance.

In Vivo. Bd. 22. H. 3. 2008 S. 279-83


Weiss, C; Faust, D; Schreck, I et al.

TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A

Oncogene. Bd. 27. H. 15. 2008 S. 2198-207